CTOs on the Move

MedImpact

www.medimpact.com

 
MedImpact Healthcare Systems, Inc. is the nation’s largest privately held pharmacy benefit management (PBM) company, serving health plans, self-funded employers and government entities. Our business model is unique: avoiding conflicts of interest by not dispensing drugs. MedImpact is focused on effectively managing client pharmacy benefits to facilitate better trend management and improved outcomes. We work with clients to direct prescribing to the lowest-net-cost, medically appropriate drug. Our number one goal is client satisfaction by providing flexible solutions and consumer-driven products with a focus on lowest net cost and quality outcomes.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.medimpact.com
  • 10181 Scripps Gateway Ct.
    San Diego, CA USA 92131
  • Phone: 858.566.2727

Executives

Name Title Contact Details

Similar Companies

Alpha Medical

Your doctor’s office is now online. From primary care to mental health, we’ve got you covered.

Spherix Inc

Spherix Incorporated was launched in 1967 as a scientific research company.  Spherix is committed to advancing innovation by active participation in the patent market. Spherix draws on portfolios of pioneering technology patents to partner with and support product innovation.

Corporate Health Systems

Corporate Health Systems is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.  

EHP Inc

EHP Inc is a Lancaster, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.